|Bid||10.76 x 1100|
|Ask||19.40 x 800|
|Day's Range||18.55 - 19.48|
|52 Week Range||13.02 - 27.85|
|Beta (5Y Monthly)||1.64|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We’re in interesting times, there’s no doubt about that. The COVID crisis is receding, the economic reopening is proceeding apace – but there are inflationary worries. The Biden Administration is committed to a heavy spending program, including generous extended unemployment benefits – which in some cases can exceed wages. As a result, the labor market is apparently stuck, running in low gear and prompting some concern that the recovery may not gain traction. Taking a macro view of the economic
View more earnings on SNDXSee more from BenzingaClick here for options trades from BenzingaInflaRx's Vilobelimab Hits Primary Endpoint Goal In Late-Stage ANCA-Associated Vasculitis StudyMinerva Shares Surge As Schizophrenia Candidate Shows Long Term Improvement In Negative Symptoms, Functioning© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Potential Syndax Pharmaceuticals, Inc. ( NASDAQ:SNDX ) shareholders may wish to note that the Independent Chairman...